•‹³E“cŒû@—S
¶‚¢—§‚¿1979”N¶‚Ü‚ê
2003”N3ŒŽ é‹Ê‘åŠw —Šw•” •ªŽq¶•¨Šw‰È ‘²‹Æ
2005”N3ŒŽ “Œ‹ž‘åŠw‘åŠw‰@ ”_Šw¶–½‰ÈŠwŒ¤‹†‰È ‰ž—p¶–½HŠwêU CŽm‰Û’ö C—¹
2009”N3ŒŽ “Œ‹ž‘åŠw‘åŠw‰@ ˆãŠwŒnŒ¤‹†‰È •ªŽq×–E¶•¨ŠwêU ˆãŠw”ŽŽm‰Û’ö C—¹
2009”N4ŒŽ “Œ‹ž‘åŠwˆã‰ÈŠwŒ¤‹†Š•ªŽq”Šà•ª–ì “Á”CŒ¤‹†ˆõ
2012”N5ŒŽ “Œ‹ž‘åŠwˆã‰ÈŠwŒ¤‹†Š•ªŽq”Šà•ª–ì •‹³
Žï–¡
ƒoƒŒ[ƒ{[ƒ‹
—”O
s“®
‹ÆÑ
- Taguchi, Y., Kiga, Y., Gohda, J. and Inoue, J. Identification and characterization of anti-osteoclastogenic peptides derived from the cytoplasmic tail of RANK. J. Bone Miner. Metab. in press (2012)
- Taguchi,Y., Gohda, J., Koga,T., Takayanagi, H., and Inoue, J.
A unique domain in RANK is required for Gab2 and PLCƒÁ2 binding to establish osteoclastogenic signals.
Genes Cells., 14(11):1331-45. (2009) - ‘æ27‰ñ “ú–{œ‘ãŽÓŠw‰ïŠwpW‰ïu—DGƒ|ƒXƒ^[‰‰‘èÜv(2009”N“x)
- ‘æ8‰ñ‚ª‚ñ“Á’è—̈挤‹†EŽáŽèŒ¤‹†ŽÒƒ[ƒNƒVƒ‡ƒbƒvuÅ—DGÜv(2007”N“x)